Sign in / Join Now
ETFs & Funds
Cancer Genetics: Major Upside Through Proprietary Tests $
Add a reply...
Latest StockTalks »
people get CGIX breaking news and analysis by email alert.
Get email alerts on CGIX »
Cancer Genetics, Inc.
Get latest price
From other sites
Cancer Genetics, Inc. Is Selected By BeiGene, Ltd. To Collaborate On Clinical Trial Services & Advance Portfolio Of Novel Oncology Therapeutics
at TheStreet (Wed, 7:54AM)
Cancer Genetics, Inc. Listed By Merck As A National Reference Laboratory For KEYTRUDA® (pembrolizumab) Companion Diagnostic Testing
at TheStreet (Mon, 8:15AM)
Cancer Genetics, Inc. And Leading Collaborators To Present Innovative Insights That Will Advance Precision Medicine In Diffuse Large B-cell Lymphoma (DLBCL) At American Society Of Hematology (ASH) Annual Meeting 2016
at TheStreet (Thu, 9:21AM)
Cancer Genetics, Inc. Ranked Among Fastest Growing Companies For Third Consecutive Year By Deloitte's Technology Fast 500™ - Ranks 233 In 2016
at TheStreet (Nov 16, 2016)
Cancer Genetics, Inc. Announces Strong Third Quarter With 68% Year Over Year Revenue Growth And Highlights Path To Future Profitability
at TheStreet (Nov 10, 2016)